@WSJ 4 years ago States resumed offering Johnson & Johnson’s Covid-19 vaccine this weekend following a pause over blood-clotting concerns #WSJWhatsNow t.co
@axios.com 4 years ago FDA analysis finds Johnson & Johnson COVID vaccine is safe and effective
@WSJ 4 years ago Use of Johnson & Johnson's Covid-19 vaccine should resume, U.S. health regulators said. The shots could be back in circulation as soon as this weekend. on.wsj.com
@WSJ 4 years ago Johnson & Johnson bet big on a new vaccine technology a decade ago. It paid off this weekend with U.S. approval of its Covid-19 shot. Here's how they did it. on.wsj.com
@vox.com 4 years ago FDA advisers unanimously recommend Johnson & Johnson’s Covid-19 vaccine